Print

TransForm Pharmaceuticals, Inc. Receives Milestone Payment From AstraZeneca (AZN) 
10/19/2005 5:12:20 PM

TransForm Pharmaceuticals, Inc. (TransForm) announced today that it received an initial milestone payment in connection with having successfully concluded a series of crystallization studies under its relationship with AstraZeneca.
//-->